The pharmacy is now in our new location at 22629 Twain Harte Drive, Suite D, Twain Harte, CA 95383!
Download our NEW mobile app!
Please be advised the pharmacy hours have changed on Fridays & Saturdays:
Friday - 9am to 6pm (Closed 1pm to 2pm for Lunch)
Saturday - Closed
Patient Resources
Get Healthy!
Living Near Busy Road Could Raise Your Odds for Eczema
- February 15, 2023
- Cara Murez HealthDay Reporter
How close a person lives to a major road could have an impact on their eczema risk.
New research suggests that folks who live farther from one are less likely to develop the skin condition.
A 13-year medical chart review focused on patients in Denver, from infants to age 18.
Those with eczema were compared to an equal-sized control group of patients without the condition. In all, the study included more than 14,000 children.
The researchers calculated the distance from their homes to a road with annual traffic of more than 10,000 vehicles a day.
The risk of eczema (atopic dermatitis) dropped 21% for every 10-fold increase in distance from a major road, the study found.
"In the end, we found children who lived 1,000 meters [0.6 miles] or more from a major road had 27% lower odds of atopic dermatitis compared to children who lived within 500 meters of a major road,"said lead author Dr. Michael Nevid, a fellow at National Jewish Health in Denver, who pursued this research after learning about a similar study in Asia.
"This is an early association study, so more work needs to be done to examine the pathophysiological mechanisms involved in the association,"Nevid said in a news release from the American Academy of Allergy, Asthma & Immunology.
The findings were published in a February online supplement to The Journal of Allergy and Clinical Immunology. They are also scheduled to be presented during a meeting in San Antonio of the American Academy of Allergy, Asthma & Immunology, Feb. 24 to 27.
More information
The National Eczema Association has more on eczema and the environment.
SOURCE: American Academy of Allergy, Asthma & Immunology, news release, Feb. 3, 2023
